Table 1.
Disease | Parasite | miRNAs | Target genes | Biological mechanism | Sources | Ref |
---|---|---|---|---|---|---|
Malaria | P. falciparum | miR-451 ↑ | PKA-R | Regulation of erythropoiesis | RBCs | (Xue et al. 2008; LaMonte et al. 2013; Chamnanchanunt et al. 2015) |
miR-223 ↑ | Unknown | |||||
let-7i ↑ | REX1 | Red cell remodeling | ||||
miR-146a ↓ | IRAK1 and TRAF6 | Control TLR-receptor signaling | Placental samples | (Van Loon et al. 2019; Taganov et al. 2006) | ||
P. vivax | miR-451 ↓ | PKA-R | Regulation of erythropoiesis | RBCs and plasma | (Chamnanchanunt et al. 2015) | |
miR-16 ↓ | Unknown | |||||
miR-221 ↓ | Bone marrow | (Baro et al. 2017) | ||||
miR-222 ↓ | ||||||
miR-24 ↓ | ||||||
miR-191 ↓ | ||||||
miR-144 ↑ | ||||||
miR-150 ↑ | ||||||
Leishmaniasis | L. major | miR-9 ↑ | NFKB1 | Control TLR-receptor signaling | Macrophages | (Guerfali et al. 2008; Bazzoni et al. 2009; Lemaire et al. 2013) |
miR-132 ↑ | ||||||
miR-155 ↑ | Myd88 and TRIF | |||||
miR-187 ↑ | Unknown | |||||
miR-146a ↑ | TRAF6, IRAK1 | |||||
let-7a ↑ | CCL2, CCL5, CXCL10, CXCL11, and CXCL12 | Inhibits macrophages stimulation | ||||
miR-25 ↑ | ||||||
miR-26a ↑ | ||||||
miR-132 ↑ | ||||||
miR-140 ↑ | ||||||
L. braziliens | miR-361-3p ↑ | TNF, GZMB, and FLG2 | Worsening of tissue damage | Skin biopsies sample | (Lago et al. 2018) | |
miR-140-3p ↑ | NKG7 | |||||
miR-193b ↓ | CD40 | Regulation of inflammatory response | (Nunes et al. 2018) | |||
miR-671 ↑ | TNFR | |||||
L. infantum | miR-210 ↓ | Procaspase-3 | Inhibition of cell apoptosis | Macrophages | (Lemaire et al. 2013) | |
miR-346 ↑ | TAP1, RFX1, and BCAP31 | Modulation of an immune response | (Diotavelli et al. 2018) | |||
L.donovani | miR-21 ↓ | SMAD7 | Regulation of TGF-β signaling | Monocytes | (Geraci et al. 2015) | |
miR-146b-5p ↑ | TRAF6 | |||||
miR-30a-3p ↑ | BECN1 | Inhibition of autophagic mechanism | Monocytes and macrophages | (Singh et al. 2016) | ||
miR-122 ↓ | DICER1 | Alteration of lipid metabolism | Huh7 cells | (Ghosh et al. 2013) | ||
Amoebiasis | E. hystolytica | miR-526b-5p ↑ | XIAP, BAK1, BNIP3L | Induces cell cycle arrest, tumor suppression, and apoptosis | Epithelial colon cells | (Lopez-Rosas et al. 2019) |
miR-643 ↑ | XIAP, BCL2L1, BCL2L10, BCL2L11, BCL2L14, API5 | |||||
miR-615-5p ↑ | BCL2L1, BCLAF1, BMF, AIFM3, AATK | |||||
miR-525 ↑ |
BCL2L1, BLC2L13, BAG3, BAG1, XIAP, CASP7, BMF |
|||||
miR-150 ↑ | BCL2L2, NAIF1, CASP7, CASP8, AIFM3, AIFM2, CFLAR | |||||
miR-409-3p ↓ | BCL2, BCL2L11, BCL2L15 | |||||
Chagas Disease | T.cruzi | miR-208a ↑ | GATA4 and GJA5 | Regulation of TGF-β signaling | Plasma | (Linhares-Lacerda et al. 2018) |
miR-19a-3p ↑ | NPPB | Induces cardiomyocyte hypertrophy | Serum and heart biopsy sample | (Nonaka et al. 2019) | ||
miR-29b-3p ↑ | ||||||
miR-30a-5p ↑ | ||||||
miR-199b-5p ↑ | Heart biopsy sample | |||||
miR-21-5p ↑ | COL1A1 | Regulation of TGF-β signaling | ||||
Schistosomiasis | S. japonicum | miR-150-5p ↑ | KANK4, DRD1, and MT1H | Actin reorganization and cell contractility | Liver sample | (Cabantous et al. 2017) |
miR-146b-5p ↑ | Unknown | Regulation of lipid metabolism | ||||
miR-143-3p ↑ | PL1N1 and VNN1 | Induces late fibrosis | ||||
miR-199a-3p ↑ | Accumulation of triglycerides | |||||
miR-10a-5p ↑ | KANK4 and VNN1 | Regulation of TGF-β signaling | ||||
miR-4521 ↑ | CTNNA3 | Reorganization of extracellular matrix | ||||
miR-31-5p ↑ | Unknown | Live fibrosis progression | ||||
miR-222-3p ↑ | KANK4 and SLC39A8 | |||||
miR-221-3p ↑ | DRD1 | |||||
miR-663b ↓ | GBP5 | Oxidative stress damage | ||||
Bantam* | Unknown | Unknown | Serum | (Meningher et al. 2016) | ||
miR-2c-3p* | ||||||
miR-3488* | ||||||
miR-2a-5p* | ||||||
Toxoplasmosis | T. gondii | miR-125 ↑ | Unknown | Inhibition of apoptosis | Macrophages | (Cai et al. 2013, 2014) |
miR-27b ↑ | ||||||
miR-30c ↑ | ||||||
miR19a ↑ | BIM | |||||
miR-19b ↑ | ||||||
miR-20a ↑ | ||||||
miR-17 ~ 92 cluster ↑ | HFF | (Zeiner et al. 2010) | ||||
miR-106b ~ 25 cluster ↑ | Unknown | |||||
miR-146a ↑ | IRAK1 and TRAF6 | Control TLR-receptor signaling | HFF-Me49 infected cells | (Cannella et al. 2014) | ||
miR-146a ↓ | HHF-RH infected cells | |||||
miR-132 ↑ | APAF1, KRAS, MAPK3, and PPP2R5E | Regulation of cell apoptosis and immune response | Neuroepithelial cells | (Ngô et al. 2017; Xiao et al. 2014) | ||
Cryptosporidiosis | C. parvum | let-7 family ↓ | SNAP23 and SOCS4 | Activation of TLR4/ NF-kB signaling | Biliary epithelial cells | (Hu et al. 2010, 2013) |
miR-27b ↑ | KSRP | (Zhou et al. 2012) | ||||
miR-98 ↓ | SOCS4 | Regulation of cytokine signaling | (Hu et al. 2010; Sato et al. 2017) | |||
miR-34b-5p ↓ | ELAVL1, RAB10, RAB14 | Regulation of cell apoptosis and immune response | HCT-8 cells | (Wang et al. 2019) | ||
miR-3591-3p ↓ | ELK4, SOS2, TAB2, DAXX, FGF14, MAPK3 | |||||
miR-18b-3p ↓ | Unknown | |||||
miR-3976 ↓ | ||||||
Clonorchiasis | C. sinensis | miR373 ↑ | MMP9 | Modulation of cell adhesion, migration, invasion, and metastasis | HuCCT1 cells and H69 cells | (Pak et al. 2014) |
miR24 ↑ | PTP | |||||
miR342-5p ↑ | AKT1 | Activation of proinflammatory mediators | ||||
miR181d ↑ | CDH13 and RASSF1 | Inactivation of tumor suppressor genes via hypermethylation | ||||
miR31 ↑ | LAST2 and PPP2R2A | Inhibition of cancer prevention pathways | ||||
miR185 ↑ | PTEN and PTPN13 | |||||
miR136 ↑ | Unknown | Cell proliferation and inhibition of tumor suppression | ||||
miR-95 ↑ | ||||||
miR-93 ↑ | ||||||
miR-153 ↑ | ||||||
miR-16-2 ↑ | ||||||
miR-195 ↑ | Suppression of cell growth | |||||
miR-199a-3p ↑ | CAV2 | Increases the proliferative and survival cell activities | ||||
let7i ↓ | TLR4, RAS, MYC, and HMGA2 | Inhibition of proliferation and differentiation of tumor cells | ||||
let7a ↓ | ||||||
miR-124 ↓ | STAT3 and EZH2 | Inhibition of cell proliferation. Induction of apoptosis, and suppression of tumor growth | HuCCT1, H69, HepG-2, and gastric cancer cells | |||
Echinococcosis | E. granulosus | let-7g-5p ↑ | IL-13, IL-10, and IL-6 | Proliferation and activation of macrophages, inflammation, apoptosis and oxidative damage | Whole blood samples | (Mariconti et al. 2019) |
let-7a-5p ↑ | ||||||
miR-26a-5p ↑ | TMEM184B | Increases the expression of type I IFN | ||||
miR-26b-5p ↑ | PTEN | Modulation of NF-κB pathway | ||||
miR-195-5p ↑ | BCL2 | Promotion of apoptosis | ||||
miR-16-5p ↑ | ||||||
miR-30c-5p ↑ | Unknown | Regulation of the innate immunity, type I IFN signaling | ||||
miR-223-3p ↑ | GZMB and HDAC2 | |||||
egr-miR-71* | Unknown | Unknown | Plasma | (Alizadeh et al. 2020) | ||
egr-let-7* | ||||||
miR-19↓ | COL1A1 and COL3A | Suppression of cell proliferation by blocking signal transmission in the TGF-β pathway | LX-2 cells and liver tissue | (Zhang et al. 2016) | ||
E. multilocularis | miR-483-3p ↑ | LBR | Promotes wound healing and cancer progression | Plasma | (Ren et al. 2019) |
*Parasite derived miRNAs
↑Indicates upregulated
↓Indicates downregulated